Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3917 results

Sort By:

Predicting and Monitoring Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using the Mansoura Scoring System

Study ID: NCT07024355
Start Date: 2026-04-01
End Date: 2027-04-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI

Study ID: NCT05880355
Start Date: 2026-04-01
End Date: 2029-01-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

60

Intervention / Treatment

To Dapansutr

Placebo

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Study ID: NCT06801223
Start Date: 2025-08-30
End Date: 2028-05-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)

Sponsor

Innoviva Specialty Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Study ID: NCT06888323
Start Date: 2025-07-31
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Actinium and 225 Lintuzumab

Biospecimen Collection

Bone Marrow Aspiration

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer

Study ID: NCT06950008
Start Date: 2025-09-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

Educational Intervention

Patient Navigation

Survey Administration

Telephone-Based Intervention

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I

Study ID: NCT06978608
Start Date: 2025-09-01
End Date: 2026-02-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Careggi Hospital-University

Source: clinicaltrials.gov

Share:
Add to list

Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Study ID: NCT05731050
Start Date: 2026-06
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

6

Intervention / Treatment

Nm8074

Sponsor

NovelMed Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Shield Post-Approval Study Protocol

Study ID: NCT06880055
Start Date: 2025-09-01
End Date: 2030-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3375

Intervention / Treatment

Shield Blood Test for colo-rectal cancer Screening

Sponsor

Guardant Health, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Group Advanced Care Planning Pilot for Veterans

Study ID: NCT06646614
Start Date: 2025-12-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Group Advance Care Planning Education

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

Study ID: NCT07032714
Start Date: 2025-12-16
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

25

Intervention / Treatment

Talkqueamab

Mezigdomide

Dexamethasone

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list